Although cardiovascular diseases represent an impressive burden on global health as they result in increased morbidity, life-long medical care and increased mortality, 1 yet there is an overall paucity of studies assessing prevalence, severity and impact of malnutrition on cardiovascular patients' outcome. This is particularly true for patients undergoing invasive treatments that may impair nutritional status. 2 For these reasons, we recently started to screen nutritional risk in patients scheduled for cardiovascular rehabilitation following treatment for ischemic or valvular heart disease using the NRS-2002 tool. In particular, we were interested in assessing the prevalence of increased nutritional risk and its relationship with previous cardiovascular treatment, as well as standard anthropometrics. 3 We here report a preliminary analysis (data presented as mean ± s.d.) based on 221 patients, consecutively enrolled 1-6 months after cardiologic treatment, with a mean age of 61.9±11.2 years (range: 25-84 years). Regarding the treatment received, most of the patients underwent percutaneous coronary intervention (PCI; n ¼ 108) or surgery (n ¼ 100), and only 13 patients received conservative treatment. Surgical procedures included coronary artery bypass graft (n ¼ 86) and valvular surgery (n ¼ 28). Prevalence of atrial fibrillation, diabetes and severity of impairment of left ventricle systolic function were not significantly different among the treatment groups.
The analysis of nutritional status revealed that, based on their BMI, half of the patients (n ¼ 110) could be defined as overweight, whereas 34% were obese. However, NRS-2002 score at baseline was 3.7±1.6, and weight loss history since cardiologic intervention 7.5 ± 4.3%. NRS X3 was found in 76.9% (n ¼ 170) patients. Using Spearman's r, we found that NRS-2002 scores significantly correlated with the age of patients (r ¼ 0.542; Po0.001), but not with left ventricle ejection fraction (r ¼ À 0.046; P ¼ 0.504). Also, NRS-2002 and weight loss progressively and significantly increased from patients undergoing surgery to those receiving PCI to conservative treatment. Finally, weight loss significantly increased with the age of the patients (r ¼ 0.360; Po0.001) and revealed a negative correlation with left ventricle end diastolic dimension (rcc ¼ À 0.256; P ¼ 0.023).
Our study reveals that cardiologic treatments differentially impact on patients' weight loss. In fact, more invasive treatments lead to greater nutritional risk due to increased metabolic demands, stress, tissue damage or healing, infections and inflammatory reaction. 4 Surgery was associated with greater weight loss when compared with conservative treatments or PCI. In our population, the type of surgery did not influence NRS-2002, although a trend could be observed between higher NRS-2002 scores and greater weight loss in patients with ischemic heart disease when compared to those with valvular disorders. 5 Of specific interest was the lack of consistency between nutritional risk scores and anthropometric measures, which strengthens the relevance of routinely performing nutritional screening and highlights the potential impact of sarcopenic obesity in cardiovascular patients.
On the basis of our results, it appears that the severity of the underlying disease or the invasiveness of the cardiologic treatment exacerbate nutritional risk. Recognizing nutritional risk in cardiovascular patients may help in better assessment of clinical risks and outcome. Therefore, assessment of nutritional status in cardiologic patients may improve evaluation of short-term risks, beyond its reliability in long-term prognosis.
